The health emergency precipitated by the Zika virus is a salutary reminder: global preparedness for emerging pathogens with endemic or pandemic potential is crucial and needs an overhaul. These crises are not rare — Lassa fever, Ebola virus, Middle East respiratory syndrome, H1N1 influenza and severe acute respiratory syndrome (SARS) have surfaced in head-spinning succession over the past 10–15 years. Each emergence proves how woefully unprepared the global community is to deal with worldwide health emergencies that have deep societal and economic impact.

Order of the United States District Court in the matter of Budha Ismail Jam & Others Vs International Finance Corporation dated 24/03/2016 regarding environmental and social harm caused by the coal-fired Tata Mundra Power Plant to the marine ecosystem, to the quality of the air, to plaintiffs’ (fishermen and farmers) health, and to their way of life.

Complaint dismissed. The World Bank's International Finance Corporation (IFC) is shielded by immunity and cannot be sued in the United States, the U.S. District Court judge ruled.

The slow global response to the Ebola crisis in west Africa suggests that important gaps exist in donor financing for key global functions, such as support for health research and development for diseases of poverty and strengthening of outbreak preparedness. In this Health Policy, we use the International Development Statistics databases to quantify donor support for such functions.

Addressing the shortfall, commissioned by WaterAid and written by Development Initiatives, puts the water and sanitation sector resourcing under the spotlight and argues that donor countries should act with urgency to increase their financing and better target their money at the 783 million lacking water and the 2.5 billion lacking sanitation.

The current drug discovery paradigm in the West is constrained in what it can do, primarily due to the funding model. Here we envisage a hypothetical non-governmental, non-profit organization called the Centre for Affordable Medicine. By sourcing innovation from a network of academic and corporate partners, and working primarily in India, it could lower the cost of innovation. Funding could be from a variety of players that expect a social, not financial, return.

Performance-based financing is generating a heated debate. Some suggest that it may be a donor fad with limited potential to improve service delivery. Most of its critics view it solely as a provider payment mechanism.

Poverty reduction lies at the core of the global development challenge. For the international development community, this objective serves not only as a source of motivation, but as a defining theme across its work. Many of the world

Aid agencies are well resourced and quick to act, but not enough of them appear to be using their power to tackle the long term problems posed by climate change. Aid agencies are first on the scene of many of the world's trouble spots, and often play a huge role in helping communities get back on their feet.

The PATH Malaria Vaccine Initiative (MVI), the main public

The policy assessment findings that emerge from the report intends to deliver a strategic summary of the current policy frameworks on water resources and climate change among major donor organizations (DANIDA, DFID, DGIS, GTZ, SDS, and USAID) and indicate areas that could be strengthened and/or gaps to fill in these two policy areas.

Pages